-
Innovation Ranking
NewInnovation Ranking – Levi Strauss & Co
Levi Strauss & Co (Levi Strauss) is a designer, manufacturer and marketer of apparel and accessories for men, women and kids. The company’s product range includes tops, jeans, shorts, skirts, jackets, casual and dress pants, activewear, footwear, watches, and accessories. The company markets its products under Levi's, Beyond Yoga, Dockers, Denizen and Signature by Levi Strauss brand names. It sells products directly through third parties and licensees such as dedicated stores, brand dedicated stores, franchise stores, company-owned stores, specialty retailers,...
-
Innovation Ranking
NewInnovation Ranking – Strauss Group Ltd.
Strauss Group Ltd (Strauss Group), formerly known as Strauss-Elite Ltd, manufactures, markets, and sells food products and non-alcoholic beverages. The company’s product portfolio includes yogurts, soft cheeses, dairy desserts, flavored milk beverages, salads, pasta products, cut vegetables, cereal bars, and olive oils. It also offers chocolate and confectionery, spreads, chewing gum, cakes, cookies and biscuits, wafers, salty snacks, and fresh juices. The company sells products through food chains, grocery stores, mini markets, supermarkets, snack bars, and kiosks. It has business...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Benralizumab in Churg-Strauss Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Benralizumab in Churg-Strauss Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Benralizumab in Churg-Strauss Syndrome Drug Details: Benralizumab (Fasenra) is a glyco-engineered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tezepelumab in Churg-Strauss Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tezepelumab in Churg-Strauss Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tezepelumab in Churg-Strauss Syndrome Drug Details: Tezepelumab-ekko (Tezspire) is a first-in-class...
-
Product Insights
Strauss Wind Farm
Strauss Wind Farm is an Onshore Wind project located in California, United States. The project is owned by Strauss Wind LLC and is developed by Pacific Renewable Energy Generation LLC; Strauss Wind LLC. The project is currently under construction. Empower your strategies with our Strauss Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Benralizumab in Skin Rash
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Benralizumab in Skin Rash report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Benralizumab in Skin Rash Drug Details: Benralizumab (Fasenra) is a glyco-engineered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tezepelumab in Cat Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tezepelumab in Cat Allergy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tezepelumab in Cat Allergy Drug Details: Tezepelumab-ekko (Tezspire) is a first-in-class...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tezepelumab in Rhinosinusitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tezepelumab in Rhinosinusitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tezepelumab in Rhinosinusitis Drug Details: Tezepelumab-ekko (Tezspire) is a first-in-class human monoclonal antibody...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tezepelumab in Chronic Urticaria Or Hives
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tezepelumab in Chronic Urticaria Or Hives report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tezepelumab in Chronic Urticaria Or Hives Drug Details: Tezepelumab-ekko...
-
Company Insights
Innovation and Patenting activity of Strauss Group Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Strauss Group Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...